Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (56)
- Committees and advisory bodies (45)
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
247 result(s) found, displaying 151 to 175
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsOn Monday, 2 December 2019, a TGA Progress Report to the Senate Mesh Inquiry was tabled in the Senate.
-
Corporate reportsFurther comments received on the consultation
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper, regulation of software, including Software as a Medical Device (SaMD).
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for the year 2018-19
-
Corporate reportsPublication of submissions to the public consultation paper proposed changes to the classification of active implantable medical devices and their accessories.
-
Corporate reportsPublication of submissions to the public consultation paper potential reclassification of active medical devices for diagnosis and patient therapy.
-
Corporate reportsPublication of submissions to the public consultation paper proposed new classification rule for medical devices that administer medicines or biologicals by inhalation.
-
Corporate reportsPublication of submissions to the public consultation paper proposed changes to the classification of medical devices used in direct contact with the heart, central circulatory or central nervous systems.
-
Corporate reportsPublication of submissions to the public consultation paper proposed reclassification of spinal implantable medical devices.
-
Corporate reportsThe 2018-19 Annual Performance Statistics Report is now available
-
Corporate reportsThe TGA thanks respondents who provided submissions
-
Scheduling submissionsPublic submissions in response to the June 2019 ACMS/ACCS/Joint meetings
-
Corporate reportsProfessor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
-
Corporate reportsA factsheet to support consumers following a recall of Allergan Biocell breast implants.
-
Corporate reportsSummary of our actions following the 2018 TGA stakeholder survey
-
Corporate reportsYou can help by sharing our messages on social media, your website and around your workplace.
-
Corporate reportsSubmissions received on the Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia have been published.
-
Scheduling submissionsPublic submissions in response to the March 2019 ACMS/ACCS/Joint interim decision
-
Scheduling submissionsOutcomes of the public consultation on Appendix M of the Poisons Standard are now available
-
-
Corporate reports
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Corporate reportsThe Action Plan will further improve Australia’s medical device regulatory system and place patient safety first